But, less than two months later, the company is in a state of free fall. Its collapse reflects not simply the troubles of the ...

A significant influence on a stock price, at least over the short term, is how a company's quarterly earnings are perceived.

It’s the latest in a surge of lawsuits for the beleaguered health care giant, and the company has denied the allegations.

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

Pfizer offers a dividend yield over 7%, but it's payout probably won't rise very fast in the decade ahead. Investors seeking ...

UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory ...

UnitedHealth Group's new CEO Steve Hemsley on Monday apologized for the company's recent earnings underperformance, and vowed ...

US insurance behemoth UnitedHealth Group is suing The Guardian for defamation weeks after the British-based newspaper ...

UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

Humana has endorsed similar policies as Congress seeks spending reductions to offset the cost of President Donald Trump's tax cuts.

The company and other insurers have faced backlash from patients who say they were denied necessary care and providers say ...

UnitedHealth Group plans to stop paying commissions next month to brokers and sales agents who sell new Medicare Part D prescription drug plans. The insurer, which has had a rough week that's ...